Advertisement

Lung

pp 1–8 | Cite as

Characterization and Triggers of Dyspnea in Patients with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure: Effects of Weather and Environment

  • Ayham Daher
  • Michael Matthes
  • András Keszei
  • Vincent Brandenburg
  • Tobias Müller
  • Christian Cornelissen
  • Michael Dreher
COPD
  • 24 Downloads

Abstract

Background and Objectives

Dyspnea is one of the most disturbing symptoms for patients with chronic obstructive pulmonary disease (COPD) or heart failure (HF). This study investigated dyspnea triggers and factors associated with worsening dyspnea in patients with COPD or HF.

Methods

COPD support group members and HF patients with reduced ejection fraction (HFrEF) and no airway obstruction answered a questionnaire describing different weather conditions (rising/falling air pressure, sunny, foggy, rainy, windy, snowy, hazy, high ozone levels, and airborne pollen) and environmental circumstances (cooking, grilling, perfumes, cigarette smoke, gasoline odor, and flower scents) and were asked to estimate the occurrence and severity of dyspnea under these conditions using predefined scales.

Results

230 patients with COPD and 90 with HFrEF (left ventricular ejection fraction 34 ± 10%, Tiffeneau index > 70%) were analyzed. COPD patients reported dyspnea more often than HF patients in almost all weather and environmental conditions (p = 0.004 to p < 0.001), with the exception of outdoor floral scents and cigarette smoke. Severe to very severe dyspnea was reported more in COPD versus HF in all weather and environmental conditions except sunny weather (p = 0.01 to p < 0.001). COPD was associated with more severe dyspnea than HF in all conditions (all p < 0.001).

Conclusions

Dyspnea was triggered by a variety of weather and other environmental triggers in patients with COPD and occurred more often than in HF patients under the same conditions. Foggy weather and exposure to perfumes were associated with severe dyspnea in the majority of COPD patients, but only a minority of HF patients.

Keywords

Chronic obstructive pulmonary disease Dyspnea Environment Heart failure Weather 

Notes

Acknowledgements

The authors thank the patients who took part in the study and the staff of the Center for Translational & Clinical Research Aachen (CTC-A) for their help with the collection of the data.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Compliance with Ethical Standards

Conflict of interest

The authors state that they have no competing interests relating to this manuscript.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) (2017) http://goldcopd.org. Accessed 08 Apr 2018
  2. 2.
    O’Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, Gelb AF, Mahler DA, Webb KA (2007) Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 4:145–168.  https://doi.org/10.1513/pats.200611-159CC CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Kraai IH, Vermeulen KM, Luttik MLA, Hoekstra T, Jaarsma T, Hillege HL (2013) Preferences of heart failure patients in daily clinical practice: quality of life or longevity? Eur J Heart Fail 15:1113–1121.  https://doi.org/10.1093/eurjhf/hft071 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Rutten FH, Moons KGM, Cramer M-JM, Grobbee DE, Zuithoff NP, Lammers JW, Hoes AW (2005) Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. Br Med J 331:1379.  https://doi.org/10.1136/bmj.38664.661181.55 CrossRefGoogle Scholar
  5. 5.
    Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130–139.  https://doi.org/10.1093/eurjhf/hfn013 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Maisel AS (2006) How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 151:999–1005.  https://doi.org/10.1016/j.ahj.2005.10.017 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Hoyer J, Reusch A, Leibing E (1999) Accuracy of interoception and withdrawal of attention in airway diseases: bronchial asthma versus chronic obstructive bronchitis. Verhaltenstherapie 9:140–147.  https://doi.org/10.1159/000030693 CrossRefGoogle Scholar
  8. 8.
    von Leupoldt A, Dahme B (2007) Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respir Med 101:411–422.  https://doi.org/10.1016/j.rmed.2006.06.011 CrossRefGoogle Scholar
  9. 9.
    Borg G, Löllgen H (2001) Borg’s perceived exertion and pain scales. Dtsch Z Sportmed 52:252.  https://doi.org/10.1097/00005768-199809000-00018 CrossRefGoogle Scholar
  10. 10.
    Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA (2004) Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 169:1298–1303.  https://doi.org/10.1164/rccm.200310-1443OC CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Jenkins CR, Celli B, Anderson JA, Ferguson GT, Jones PW, Vestbo J, Yates JC, Calverley PM (2012) Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 39:38–45.  https://doi.org/10.1183/09031936.00194610 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Suzuki M, Makita H, Ito YM, Nagai K, Konno S, Nishimura M, Hokkaido COPD Cohort Study Investigators (2014) Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study. Eur Respir J 43:1289–1297.  https://doi.org/10.1183/09031936.00110213 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Seemungal TAR, Wedzicha JA (2014) Exacerbation frequency and FEV1 decline of COPD: is it geographic? Eur Respir J 43:1220–1222.  https://doi.org/10.1183/09031936.00046014 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Koskela HO, Tukiainen HO, Koskela AK (1996) Bronchoconstriction due to cold weather in COPD: the roles of direct airway effects and cutaneous reflex mechanisms. Chest 110:632–636.  https://doi.org/10.1378/chest.110.3.632 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Ren J, Li B, Yu D, Liu J, Ma Z (2016) Approaches to prevent the patients with chronic airway diseases from exacerbation in the haze weather. J Thorac Dis 8:E1–E7.  https://doi.org/10.3978/j.issn.2072-1439.2015.11.61 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Santus P, Russo A, Madonini E, Allegra L, Blasi F, Centanni S, Miadonna A, Schiraldi G, Amaducci S (2012) How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan. Respir Res 13:95.  https://doi.org/10.1186/1465-9921-13-95 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Ko FWS, Hui DSC (2012) Air pollution and chronic obstructive pulmonary disease. Respirology 17:395–401.  https://doi.org/10.1111/j.1440-1843.2011.02112.x CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Wedzicha JA, Brill SE, Allinson JP, Donaldson GC (2013) Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med 11:181.  https://doi.org/10.1186/1741-7015-11-181 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Wedzicha JA, Mackay AJ, Singh R (2013) COPD exacerbations: impact and prevention. Breathe 9:434–440.  https://doi.org/10.1183/20734735.002913 CrossRefGoogle Scholar
  20. 20.
    Mackay AJ, Hurst JR (2012) COPD exacerbations: causes, prevention, and treatment. Med Clin North Am 96:789–809.  https://doi.org/10.1016/j.mcna.2012.02.008 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    See KC, Phua J, Lim TK (2016) Trigger factors in asthma and chronic obstructive pulmonary disease: a single-centre cross-sectional survey. Singap Med J 57:561–565.  https://doi.org/10.11622/smedj.2015178 CrossRefGoogle Scholar
  22. 22.
    Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D, Laffaye N, Fuselli JJ, Massolin HP, Gambarte J, Romero M, Tognoni G (2012) Unrecognised ventricular dysfunction in COPD. Eur Respir J 39:51–58.  https://doi.org/10.1183/09031936.00044411 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pneumology and Intensive Care MedicineUniversity Hospital AachenAachenGermany
  2. 2.Department of Medical InformaticsUniversity Hospital AachenAachenGermany
  3. 3.Department of Cardiology, Angiology and Intensive Care MedicineUniversity Hospital AachenAachenGermany

Personalised recommendations